Latest Breaking News On - Pittsburgh liver research center - Page 1 : comparemela.com

New embryo-like model simulates early human blood production

New embryo-like model simulates early human blood production
phys.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phys.org Daily Mail and Mail on Sunday newspapers.

Joshua hislopMo ebrahimkhaniPittsburgh liver research centerDepartment of pathologyUniversity of pittsburghMcgowan institute of regenerative medicine pittPittsburgh liver instituteDepartment of bioengineering at pittMcgowan instituteRegenerative medicine

Novel Model Mimics Early Human Blood Formation

Novel Model Mimics Early Human Blood Formation
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Ryan legrawDonna stolzTahere mokhtariMohammad naser taheriJeremy velazquezSamira kianiKamyar keshavarzRayna schoenbergerSousa lopesSimon watkinsMo ebrahimkhaniAmir alaviJoshua hislopMatthew rytelPittsburgh liver institutePitt center

Helping the liver regenerate itself could give patients with end-stage liver disease a treatment option besides waiting for a transplant

Tylenol overdose is one of the leading causes of liver injury requiring liver transplantation. Elena Merkulova/iStock via Getty ImagesThe liver is known for its ability to regenerate. It can completely regrow itself even after two-thirds of its mass has been surgically removed. But damage from medications, alcohol abuse or obesity can eventually cause the liver to fail. Currently, the only effective treatment for end-stage liver disease is transplantation. However, there is a dearth of organs av

Satdarshan paul singh mongaUniversity of pittsburghPittsburgh liver research centerSingh mongaLiver transplantationLiver regenerationDriver injuryLiver diseaseLiver cellsFatty liver diseaseLiver functionLiver failure

MRI Contrast Agent Orviglance Hepatic Impairment Data Presented by Ascelia Pharma at ESGAR 2023

Ascelia Pharma recently presented data from its Orviglance Hepatic Impairment study showing that Orviglance, a non-gadolinium oral contrast agent, has the potential to be used in patients with any degree of liver impairment. The data was presented during the June 14-16 European Society of Gastrointestinal and Abdominal Radiology (ESGAR), held in Valencia, Spain.

United statesAlessandro furlanNikolaos kartalisAscelia pharmaAscelia pharmapresentedNadilka hettiarachchigeKarolinska university hospitalGlobal medical affairs at ascelia pharmaDepartment of radiology huddingePittsburgh liver research centerDrug administrationEuropean society of gastrointestinalTexas liver instituteOrviglance hepatic impairmentEuropean societyAbdominal radiology

Vinyl chloride released in Ohio train derailment linked to liver damage

Vinyl chloride – a chemical being transported in some of the train cars that derailed and burned in East Palestine, Ohio early this month – can harm the human liver. Data suggests that vinyl [.]

United statesEast palestineOhio riverJulianei beierHealth rangerMember of pittsburgh liver research centerUniversity of pittsburghEnvironmental healthNatural newsAssistant professorPittsburgh liver research centerClean water actHealth ranger storeCurrent eventsToxic chemicalsToxic water